What is the Future for CBD Businesses in 2022?
What is the Future for CBD Businesses in 2022? “CBD is an integral part of my training and post-fight regimen expediting my body’s natural healing process.” – Anthony Pettis Every industry has its own challenges but when it comes to the CBD...
CBD Oil for Morning Sickness: Does the Product Prove Beneficial?
CBD Oil for Morning Sickness: Does the Product Prove Beneficial? Morning sickness is one of the most daunting effects of pregnancy. At the same time, unpredictability and constant prevalence lead many women to seek relief from discomfort. And, that’s the reason...
Valens Company Announces Strategic Agreements with PMI Mexico
The Valens Company Announces Strategic Agreements with PMI Mexico • Valens to serve as exclusive supplier of CBD for PMI’s clinical trial, which will measure anti-inflammatory applications of medical-grade, nano-water emulsified CBD oil• Valens will manufacture...
CURE Pharmaceutical: Should You Buy this Cannabis Biotech Stock?
Should you buy this cannabis biotech stock CURE Pharmaceutical? CURE Pharmaceutical Holding Corp. (OTC: CURR) focuses on the development and manufacturing of drug formulation and drug delivery technologies in novel dosage forms (thin wafers and thin films). Notably,...
Hemp Wellness Segments Of CBD Market Could See the Fastest Growth Rates Through 2028
Hemp Wellness Segments Of CBD Market Could See the Fastest Growth Rates Through 2028 Out of all cannabinoids, cannabidiol is most widely used for therapeutic reasons due to the lack of psychoactive effects. In many medical applications, cannabidiol oil is used, such...
CanninPlus with Trading Alerts!
Get advance notice of profitable cannabis & hemp stock trades. Use our machine learning algorithm to start profiting from this explosive industry.
$99 / month after 7-day trial.
Still unsure? Schedule demo at [email protected]
or call 720-254-1374
The Best Cannabis Stocks for 2022
-
Cannin Report Q2 2021
$49.00
-
Cannin Report Q1 2021
$29.00
-
The Cannin Report 2020
$19.00
-
FREE Sample Cannin Report Q1 2020 - Our #1 Stock Pick
$0.00
-
The Cannin Report Q4 2019
$29.00
